193 related articles for article (PubMed ID: 34722281)
1. The Presence of Circulating Tumor Cell Cluster Characterizes an Aggressive Hepatocellular Carcinoma Subtype.
Yu JJ; Shu C; Yang HY; Huang Z; Li YN; Tao R; Chen YY; Chen Q; Chen XP; Xiao W
Front Oncol; 2021; 11():734564. PubMed ID: 34722281
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B
BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214
[TBL] [Abstract][Full Text] [Related]
3. Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular Carcinoma.
Luo Q; Wang C; Peng B; Pu X; Cai L; Liao H; Chen K; Zhang C; Cheng Y; Pan M
Front Oncol; 2020; 10():1758. PubMed ID: 33224869
[No Abstract] [Full Text] [Related]
4. Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma.
Chen J; Luo Y; Xi X; Li H; Li S; Zheng L; Yang D; Cai Z
Front Oncol; 2022; 12():931140. PubMed ID: 36465354
[TBL] [Abstract][Full Text] [Related]
5. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
Schulze K; Gasch C; Staufer K; Nashan B; Lohse AW; Pantel K; Riethdorf S; Wege H
Int J Cancer; 2013 Nov; 133(9):2165-71. PubMed ID: 23616258
[TBL] [Abstract][Full Text] [Related]
6. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L
Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the prognostic role and biological characteristics of circulating tumor cell-associated white blood cell clusters in non-small cell lung cancer.
Li Z; Fan L; Wu Y; Niu Y; Zhang X; Wang B; Yao Y; Chen C; Qi N; Wang DD; Lin PP; Tang D; Gao W
J Thorac Dis; 2022 May; 14(5):1544-1555. PubMed ID: 35693614
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.
Jansson S; Bendahl PO; Larsson AM; Aaltonen KE; Rydén L
BMC Cancer; 2016 Jul; 16():433. PubMed ID: 27390845
[TBL] [Abstract][Full Text] [Related]
10. Analysis of a Real-World Cohort of Metastatic Breast Cancer Patients Shows Circulating Tumor Cell Clusters (CTC-clusters) as Predictors of Patient Outcomes.
Costa C; Muinelo-Romay L; Cebey-López V; Pereira-Veiga T; Martínez-Pena I; Abreu M; Abalo A; Lago-Lestón RM; Abuín C; Palacios P; Cueva J; Piñeiro R; López-López R
Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32365530
[TBL] [Abstract][Full Text] [Related]
11. Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.
Wang C; Mu Z; Chervoneva I; Austin L; Ye Z; Rossi G; Palazzo JP; Sun C; Abu-Khalaf M; Myers RE; Zhu Z; Ba Y; Li B; Hou L; Cristofanilli M; Yang H
Breast Cancer Res Treat; 2017 Jan; 161(1):83-94. PubMed ID: 27771841
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma.
Guan Y; Xu F; Tian J; Gao K; Wan Z; Wang Y; Gao M; Wang Z; Chong T
BMC Cancer; 2021 Jul; 21(1):826. PubMed ID: 34271857
[TBL] [Abstract][Full Text] [Related]
13. Significance of circulating tumor cells in the portal vein regarding metastases and vascular invasion in hepatocellular carcinoma patients.
Zhao X; Zhao J; Tao L; Pan Y; Yang L; Zhang X; Yuan J; Zhu H
J Gastrointest Oncol; 2021 Dec; 12(6):3050-3060. PubMed ID: 35070429
[TBL] [Abstract][Full Text] [Related]
14. Improved Prognostic Stratification Using Circulating Tumor Cell Clusters in Patients with Metastatic Castration-Resistant Prostate Cancer.
Wang C; Zhang Z; Chong W; Luo R; Myers RE; Gu J; Lin J; Wei Q; Li B; Rebbeck TR; Lu-Yao G; Kelly WK; Yang H
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33450815
[TBL] [Abstract][Full Text] [Related]
15. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
[TBL] [Abstract][Full Text] [Related]
16. Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma.
Lei Y; Wang X; Sun H; Fu Y; Tian Y; Yang L; Wang J; Xia F
Front Oncol; 2021; 11():601668. PubMed ID: 34123777
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cell-associated white blood cell cluster is associated with poor survival of patients with gastric cancer following radical gastrectomy.
Qiu Y; Zhang X; Deng X; Zhang R; Cai Z; Zhang Z; Liu H
Eur J Surg Oncol; 2022 May; 48(5):1039-1045. PubMed ID: 34836729
[TBL] [Abstract][Full Text] [Related]
18. Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma.
Ou H; Huang Y; Xiang L; Chen Z; Fang Y; Lin Y; Cui Z; Yu S; Li X; Yang D
Dig Dis Sci; 2018 Sep; 63(9):2373-2380. PubMed ID: 29926241
[TBL] [Abstract][Full Text] [Related]
19. 3D Culture of Circulating Tumor Cells for Evaluating Early Recurrence and Metastasis in Patients with Hepatocellular Carcinoma.
Hu CL; Zhang YJ; Zhang XF; Fei X; Zhang H; Li CG; Sun B
Onco Targets Ther; 2021; 14():2673-2688. PubMed ID: 33888992
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of circulating tumor cells associated with white blood cells in solid cancer: a systematic review and meta-analysis of 1471 patients with solid tumors.
Ju M; Gao Z; Gu G; Huang H; Sun A; Zheng C; Li H; Zhang Y; Li K
BMC Cancer; 2023 Dec; 23(1):1224. PubMed ID: 38087278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]